In Alzheimer's disease and dementia, thought disorder manifests as cognitive impairment affecting memory, reasoning, and communication skills. Thought disorder in these conditions often presents as disorganized thinking, difficulty concentrating, and problems with language comprehension and expression. Patients may struggle to follow conversations or convey their thoughts clearly, leading to misunderstandings and frustration. As the diseases progress, thought disorder worsens, affecting daily functioning and independence. Caregivers play a crucial role in managing these symptoms through structured routines, clear communication strategies, and maintaining a supportive environment. Understanding and addressing thought disorder in Alzheimer's disease and dementia is essential for improving quality of life and ensuring appropriate care and support for patients and their families.
Jacqueline Tuppen
Cogs Club, United Kingdom
Yong Xiao Wang
Albany Medical College, United States
Kaoru Sakatani
The University of Tokyo, Japan
Suren A Tatulian
University of Central Florida, United States
Constantina Mizis
The Latino Alzheimer’s and Memory Disorders Alliance, United States
Paul Y Song
NKGen Biotech, United States
Marco Ruggiero
Silver Spring Sagl, Switzerland
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States